← FDA DRUG APPROVALS

FDA NDA · NDA019261

PAREMYD

Sponsor: EPIC PHARMA LLC

APPLICATION
NDA019261
TYPE
NDA
ORIGINAL APPROVAL
1992-01-30
LATEST ACTION
2013-11-05
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

PAREMYD · ReferenceDiscontinued
HYDROXYAMPHETAMINE HYDROBROMIDE 1%, TROPICAMIDE 0.25% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2013-11-05Manufacturing (CMC) · Supplement 13 · standardAP
2013-10-08Manufacturing (CMC) · Supplement 12 · standardAP
2001-12-04Manufacturing (CMC) · Supplement 8 · standardLabelAP
1997-09-18Manufacturing (CMC) · Supplement 4 · standardAP
1997-06-25Labeling · Supplement 5 · standardAP
1995-08-03Manufacturing (CMC) · Supplement 2 · standardAP
1994-02-22Manufacturing (CMC) · Supplement 3 · standardAP
1993-07-07Manufacturing (CMC) · Supplement 1 · standardAP
1992-01-30Type 4 - New Combination · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →